Taipei, Taiwan

Xiaorui Chen

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Xiaorui Chen

Introduction

Xiaorui Chen is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for combating viral infections. With a total of 2 patents, his work is crucial in the ongoing fight against diseases caused by coronaviruses.

Latest Patents

Xiaorui Chen's latest patents include an antibody specific to the spike protein of SARS-CoV-2 and its various applications. This patent discloses an antibody or antigen-binding fragment that specifically binds to the spike protein of SARS-CoV-2. The patent also outlines a pharmaceutical composition, methods for treating and preventing diseases caused by coronaviruses, and techniques for detecting the virus in samples.

Career Highlights

Xiaorui Chen is affiliated with Academia Sinica, a leading research institution in Taiwan. His work at Academia Sinica has positioned him as a key figure in the field of viral research and antibody development. His innovative approaches have garnered attention and respect within the scientific community.

Collaborations

Xiaorui Chen has collaborated with notable colleagues, including Kuo-I Lin and Che Ma. These partnerships have enhanced his research capabilities and contributed to the advancement of his projects.

Conclusion

Xiaorui Chen's contributions to the field of biotechnology, particularly through his patents related to SARS-CoV-2, highlight his role as an influential inventor. His work not only advances scientific knowledge but also plays a vital role in public health initiatives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…